Literature DB >> 28035537

A preparation model of Chinese medicine decoction placebo.

Li-Qun Bian1, Bao-Shuang Li1, Zhen-Hua Li1, Feng-Yun Wang1, Yan-Dong Wen1, Xu-Dong Tang2.   

Abstract

Chinese medicine (CM) decoction placebo is one of the key factors restricting the placebo-controlled clinical trial of CM. In this article, based on the analysis of the diffificulties in preparing CM placebo, the production requirements for placebo were put forward. Moreover, in accordance with clinical practices, a production method and evaluation process of CM decoction placebo was proposed, to provide a reference for clinical research.

Keywords:  Chinese medicine; decoction; placebo; preparation model

Mesh：

Substances：

Year:  2016        PMID： 28035537     DOI： 10.1007/s11655-016-2538-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


  6 in total

1.  [Current application of placebo in Chinese clinical studies in past 30 years].

Authors:  Sheng-ping Wu; Li-peng Xu; Yu Guo; Ya-shan Cui; Xi-yan Zhao; Yong Li; Xiao-lin Tong; Feng-mei Lan
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2015-04

2.  [Reflections into the latent contradictions between the "placebo" concept and traditional Chinese medicine].

Authors:  Xiang-Jun Lin; Rui Li
Journal:  Zhongguo Zhen Jiu       Date:  2013-03

3.  [Exploration into the preparation of placebos used in Chinese medicinal clinical trial].

Authors:  Xu-Dong Tang; Li-Qun Bian; Rui Gao
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2009-07

Review 4.  [Placebo control and clinical trial of Chinese medicine].

Authors:  Jing Wu
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2010-10

5.  [Modified Shengma Biejia Decoction Combined with CAG Program for Elderly Acute Myeloid Leuke- mia Patients with Yin Deficiency Toxin Stasis Syndrome].

Authors:  Xing-bin Dai; Xue-mei Sun; Peng-jun Jiang; Hai-wen Ni; Jian-yi Chen; Wen-xi Zhang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2016-02

6.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Authors:  Anna Caroli; Norberto Perico; Annalisa Perna; Luca Antiga; Paolo Brambilla; Antonio Pisani; Bianca Visciano; Massimo Imbriaco; Piergiorgio Messa; Roberta Cerutti; Mauro Dugo; Luca Cancian; Erasmo Buongiorno; Antonio De Pascalis; Flavio Gaspari; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2013-08-21       Impact factor: 79.321
  6 in total
  3 in total

1.  Effect of Chinese Herbal Compound LC09 on Patients With Capecitabine-Associated Hand-Foot Syndrome: A Randomized, Double-Blind, and Parallel-Controlled Trial.

Authors:  Ran Yu; Xuefeng Wu; Liqun Jia; Yanni Lou
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

2.  Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial.

Authors:  Yuanbin Chen; Lin Lin; Lei Wu; Yinji Xu; Johannah L Shergis; Anthony L Zhang; Zehuai Wen; Christopher Worsnop; Cliff Da Costa; Frank Thien; Charlie C Xue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-27

3.  Evaluation on immediate analgesic efficacy and safety of Kai-Hou-Jian spray (children's type) in treating sore throat caused by acute pharyngitis and tonsillitis in children: study protocol for a randomized controlled trial.

Authors:  Yan-Ning Ma; Cheng-Liang Zhong; Si-Yuan Hu; Qiu-Han Cai; Sheng-Xuan Guo
Journal:  Trials       Date:  2021-03-18       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.